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A Viral microRNA Down-Regulates Multiple Cell Cycle
Genes through mRNA 59UTRs
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Abstract
Global gene expression data combined with bioinformatic analysis provides strong evidence that mammalian miRNAs
mediate repression of gene expression primarily through binding sites within the 39 untranslated region (UTR). Using RNA
induced silencing complex immunoprecipitation (RISC-IP) techniques we have identified multiple cellular targets for a
human cytomegalovirus (HCMV) miRNA, miR-US25-1. Strikingly, this miRNA binds target sites primarily within 59UTRs,
mediating significant reduction in gene expression. Intriguingly, many of the genes targeted by miR-US25-1 are associated
with cell cycle control, including cyclin E2, BRCC3, EID1, MAPRE2, and CD147, suggesting that miR-US25-1 is targeting genes
within a related pathway. Deletion of miR-US25-1 from HCMV results in over expression of cyclin E2 in the context of viral
infection. Our studies demonstrate that a viral miRNA mediates translational repression of multiple cellular genes by
targeting mRNA 59UTRs.
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Introduction
The recent discovery of a new class of regulatory genes known
as microRNAs (miRNAs) has resulted in a paradigm shift in gene
regulation research. miRNAs are small single-stranded RNA
species of approximately 20–24 bases in length that regulate gene
expression through post transcriptional mechanisms [1]. Expres-
sion of miRNAs is thought to be ubiquitous among multicellular
eukaryotes [2]. In addition to eukaryotic miRNAs, more than 100
viral miRNAs have been identified, almost all of which are
expressed by herpesviruses [3]. Targets for the majority of viral
miRNAs are currently unknown due to the difficulty involved in
identifying novel target transcripts. This remains one of the major
challenges in elucidating the function of miRNAs. However,
recent reports have begun to elucidate the various roles of viral
miRNAs. These include blocking apoptosis, immune evasion and
regulation of viral replication through targeting of both cellular
and viral gene expression [4,5].
HCMV, a member of the beta-herpesvirus sub family, encodes
at least 11 miRNAs [6–8]. Previously, we demonstrated that the
HCMV encoded miRNA, miR-UL112-1, targets a number of the
virus’s own genes, including the immediate early transactivator
IE72 which is essential for driving acute replication of HCMV [9].
In addition, miR-UL112-1 targets the cellular gene MICB,
resulting in protection against recognition by natural killer cells
[10]. miR-UL112-1 may therefore play an important role in
establishing and maintaining viral latency and persistence through
regulation of viral gene expression and subversion of host antiviral
pathways. Indeed, consensus is beginning to emerge that
herpesvirus miRNAs may, in general, be important in establishing
and maintaining viral persistence [9,11–13].
Current studies indicate that miRNA targeting in mammalian
cells occurs predominantly through binding to sequences within
39UTRs [14–16]. The reason for this bias is unclear, although a
recent study demonstrated that miRNA-mediated repression of a
reporter construct was less efficient when the target site was placed
in the ORF compared to the 39UTR [17]. In contrast, inhibition
of gene expression through targeting the 59UTR has been
demonstrated, at least in the context of an artificial reporter
construct, indicating that miRNA targeting of 59UTRs is possible
[18]. However, statistical analysis of conserved miRNA target
sequences and global biochemical screens have demonstrated that
mammalian miRNA target sites rarely occur within 59UTRs
[14–16,19]. The role of 59UTRs in miRNA regulation is further
complicated by a study that found miR-10a induces, rather than
inhibits, protein expression through binding to 59UTRs of cellular
transcripts [20]. In addition, binding of the liver specific miRNA,
miR-122 to the 59UTR of Hepatitis C (HCV) genome is required
for virus replication [21]. These studies suggest a model in which
binding to the 59UTR results in mechanistic effects divergent from
39UTR binding.
Here, we identify cellular transcript targets of one of the most
highly expressed HCMV encoded miRNAs, miR-US25-1, using a
recently developed biochemical approach called RISC immuno-
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precipitation. Strikingly, the majority of identified transcripts
contained miR-US25-1 target sites within the 59UTR rather than
the 39UTR. The target transcripts include a number of genes
associated with cell cycle control, including cyclin E2, as well as
histone proteins, suggesting that miR-US25-1 is targeting
functionally related genes. Crucially, we demonstrate that
targeting of cyclin E2 by miR-US25-1 occurs in the context of
HCMV infection and results in inhibition of cyclin E2 protein
expression.
Results
Identification of cellular targets of miR-US25-1 through
RISC immunoprecipitation
Identifying target transcripts is still one of the main challenges in
determining the functional role of miRNAs. Although bioinfor-
matic strategies have proven useful, they are limited by high false
positive rates. Due to a lack of effective approaches, target
transcripts for the majority of viral miRNAs, and miRNAs in
general remain unknown. Alternative experimental approaches for
the identification of miRNA targets that do not completely rely on
bioinformatic predictions are therefore desirable. Recently,
approaches for miRNA target identification have been devised
that rely on immunoprecipitation of the RISC complex and the
associated target transcripts [22,23]. As part of the RISC complex,
miRNAs bind to target transcripts and form stable interactions.
Using a HEK293 cell line that expresses a tagged component of
RISC (Argonaute 2 (Ago2) tagged with myc epitope) these
complexes can be immunoprecipitated and targeted transcripts
identified by microarray analysis (Figure 1a). This approach was
used to identify cellular targets of one of the most highly expressed
HCMV miRNAs, miR-US25-1. The Ago2 tagged cell line was
transiently transfected with a construct encoding the full-length
pre-miRNA of miR-US25-1, under the control of the human U6
polymerase III promoter. Three days post transfection cells were
harvested and RISC complexes were immunoprecipitated with a
myc-epitope specific antibody. mRNA levels within the immuno-
precipitated complexes as well in whole cell lysates were quantified
by microarray analysis. As previously described [22,23], associa-
tion of a specific mRNA with the RISC complex is represented by
quantitative enrichment of the mRNA in the immunoprecipitated
fraction relative to the total (whole cell) fraction. In order to
determine which targets are specifically associated with miR-
US25-1, fold enrichment of transcripts immunoprecipitated from
miR-US25-1 transfected cells was compared to values from cells
transfected with a vector expressing a negative control miRNA.
miR-US25-1 specific targets are only expected to be enriched in
cells expressing miR-US25-1. Transcripts were then ranked
according to the level of enrichment with the highest enriched
transcripts considered potential targets of miR-US25-1 (Table S1).
Over all, the results indicate that miR-US25-1 RISC complexes
associated with a relatively small population of transcripts
(Figure 1b and c) and fold changes were skewed towards
enrichment as would be expected if miR-US25-1 were targeting
a specific population of genes. The majority of transcripts were not
enriched, showing enrichment levels close to 1 (Figure 1b). Thirty-
six transcripts showed greater than 2-fold enrichment, while only 1
transcript was reduced by more than 2-fold. The highest level of
enrichment was 6.5 fold.
To increase confidence in target identification, a second,
parallel approach was used in which a biotinylated synthetic
mimic of miR-US25-1 was transfected into HEK293 cells and
miR-US25-1 specific miRNA protein complexes (miRNPs) were
isolated using streptavidin bead pull downs (Figure 2a and Table
S2). In contrast to the previous approach this should only pull
down direct targets of miR-US25-1. Again, most genes showed
little or no enrichment with a relatively small population of
transcripts showing exponential increase in enrichment (Figure 2b
and c). However, the levels of enrichment were much higher
following biotin isolation, reaching a maximum of 23.6 fold. In this
case fold changes did not skew towards enrichment as miR-US25-
Author Summary
Regulation of gene expression is as important as the genes
themselves in determining the diverse array of living
creatures we see in nature. Recently, scientists have
discovered a whole new level of gene regulation through
the actions of small molecules called microRNAs (miRNAs).
It is currently thought that miRNAs regulate gene
expression primarily through binding to target sites within
the 39UTR of mRNAs. Here we identify a population of
cellular genes that are targeted by a virally encoded
miRNA. Many of the genes are related to cell cycle control,
suggesting that the viral miRNA is targeting genes within a
related pathway. In contrast to most miRNAs, this miRNA
inhibits gene expression through binding to target sites
within the 59UTRs, suggesting that viral miRNAs may
target genes through mechanisms divergent from cellular
miRNAs.
RISCRISC
Figure 1. RISC-IP analysis of HCMV encoded miRNA, miR-US25-1. (a) Schematic representation of c-myc tagged Ago2 pull downs. (b)
Distribution of fold enrichment and (c) enrichment levels of top 100 transcripts following RISC-IP analysis using c-myc tagged Ago2 approach.
doi:10.1371/journal.ppat.1000967.g001
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1 was compared to a second HCMV miRNA, miR-US5-2, rather
than a negative control. Transcripts showing a negative enrich-
ment ratio, likely represent targets of miR-US5-2.
The two data sets were compared to determine whether the
same genes were identified by both RISC pull down approaches.
As the enrichment levels in the biotin approach were higher than
those found with the myc-Ago2 approach, averaging the
enrichment levels would result in bias towards the biotin data
set. To avoid this bias, the data sets were combined using rank sum
analysis. Transcripts were assigned a rank based on the
comparative level of enrichment (highest enriched = rank 1,
lowest = rank 24526) then the average rank between the myc-
Ago2 approach and the biotin approach was calculated for each
gene. Although differences existed in the rankings of the two data
sets (for example TRIM28 was ranked 1st in the c-myc approach,
but 188th in the biotin approach) a population of transcripts were
enriched by both approaches. Fifteen of the top 20 genes showed
greater than 2 fold enrichment by both approaches, giving high
confidence that these transcripts were likely targets of miR-US25-
1. Table 1 shows the top 20 ranked genes by rank sum analysis
including a summary description of their function and the
enrichment levels by each approach. A number of these targets
are involved in cell cycle control (cyclin E2, BRCC3, PSMA4 and
EID1 [24–27]) and tumor progression (ASRGL1, CD147, MAPRE2
and ASPSCR1 [28–31]), while three of the targets encode histone
genes (LOC440093, H3F3B, HIST2H4A), indicating that miR-
US25-1 targets functionally related genes.
miR-US25-1 targets sites within the 59UTR of transcripts
If the observed enrichment were due to direct targeting by
miR-US25-1, the identified population of transcripts would be
expected to contain binding sites for the miRNA. Binding of the
59 end of the miRNA, specifically nucleotides 1–8, known as the
seed sequence, are thought to be particularly important
[1,32,33]. Therefore, the transcripts in the database were
searched for seed sequence matches complimentary to nucleo-
tides, 1–7, 2–8 and 1–8 of miR-US25-1. The number of seed
matches within the top 50 enriched transcripts from Table S3
was then compared to the number of matches within the rest of
the gene list, thereby determining whether genes highly
enriched, were more likely to contain predicted miR-US25-1
target sites. Strikingly, miR-US25-1 seed matches were signif-
icantly overrepresented within the 59UTRs of enriched genes
(Figure 3 and Table 2). Twelve of the top 20 genes shown in
Table 1 contained at least one 7 base seed match within the
59UTR. In addition, a further 3 genes contain target sites within
the 59UTRs that do not strictly adhere to Watson-Crick base
pairing within the seed region. One gene, ATP6V0C, contained
a 7 base target within the coding region, 100 bases down stream
of the 59UTR (Table 1 and Figure S1). Crucially the number of
target sites within the top 50 genes increased from 19 and 14
with the biotin and c-myc approach individually, to 24 target
sites in the combined data set, providing additional evidence
that the combined approach provides a more robust method of
identifying target transcripts.
To confirm that enrichment of identified transcripts was due to
binding of miR-US25-1 to the 59UTR, the 59UTRs and ,500
bases of upstream genomic sequence of two of the top target genes,
cyclin E2 and H3F3B, were cloned in front of a luciferase reporter
construct (Figure 4a and b). These constructs were cotransfected
into c-myc tagged Ago2 expressing 293 cells with plasmids
expressing either miR-US25-1 or the negative control plasmid.
RISC-IP analysis was conducted as described above, with levels of
luciferase transcript measured using specific RT-PCR primers to
the coding region of the reporter gene. Figure 4c shows miR-
US25-1 expression resulted in enrichment of luciferase transcript,
indicating that the 59UTRs are indeed sufficient for miR-US25-1
binding. Deletion of the identified seed sequence targets from the
59UTRs resulted in a loss of enrichment, confirming that the
59UTR sequences are sufficient and that the target sites are
necessary for miR-US25-1 binding.
Targeting of 59UTRs by miR-US25-1 results in decreased
gene expression
To determine the effect on gene expression of miR-US25-1
binding on the identified 59UTR targets, luciferase assays were
conducted using the 59UTR constructs described above. In each
case expression of miR-US25-1 resulted in a significant reduction
in luciferase activity and protein levels (Figure 4d). miR-US25-1
regulation was dependent on the cloned 59UTRs and the seed
target sites as deletion of these target sites rescued expression of
luciferase. Expression of miR-US25-1 appears to have resulted in a
greater reduction of luciferase protein as determined by western
blot, compared to luciferase activity. We speculate that the
reduction in luciferase activity is not linearly reflecting the
reduction in actually protein levels, possible due to enzymatic
nature of the luciferase assay. Direct measurement of luciferase
protein may therefore be a more sensitive measure of miRNA
regulation.
RISC RISC
Figure 2. RISC-IP analysis of HCMV encoded miRNA, miR-US25-1. (a) Schematic representation of biotin pull downs. (b) Distribution of fold
enrichment and (c) enrichment levels of top 100 transcripts following RISC-IP analysis using biotin approach.
doi:10.1371/journal.ppat.1000967.g002
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miR-US25-1 regulates expression of cyclin E2 and TRIM28
during viral infection
Although these results confirm that miR-US25-1 can bind to a
specific population of cellular transcripts, it is important to
determine whether these genes are targeted in the context of a
viral infection. HEK293 cells are not permissive to HCMV and
have a different gene expression profile than cells that are HCMV
permissive. To enable RISC-IP analysis of permissive cell lines, a
direct antibody to Ago2 was generated using a peptide from the N-
terminus of the protein. This antibody was shown to efficiently
recognize endogenous Ago2 (Figure S2a and b). RISC complexes
were immunoprecipitated from either uninfected human primary
fibroblast cells or cells infected with HCMV. The associated RNA
was isolated and subjected to RT-PCR analysis using primers
Table 1. Top 20 ranked cellular targets of miR-US25-1.
myc-Ago2 Biotin
Target ID Enrichment Rank Enrichment Rank Rank ave Target Site DEFINITION
CCNE2 5.8 2 12.2 3 2.5 +1 G1/S cyclin E2
BCKDHA 3.1 8 23.7 1 4.5 +2 branched chain keto acid dehydrogenase
LOC440093 5.7 3 6.9 12 7.5 +1 similar to H3 histone, family 3B
POP4 2.4 14 6.4 15 14.5 - ribonuclease P/MRP subunit
ATP6V0C 3.8 4 4.4 33 18.5 +3 ATPase, H+ transporting, lysosomal
ASRGL1 2.1 29 7.9 10 19.5 +1 asparaginase like 1
BRCC3 2.0 39 12.6 2 20.5 +2 G2/M transition DNA damage checkpoint
H3F3B 2.5 12 4.4 36 24 +1 H3 histone, family 3B
PSMA4 3.1 7 4.0 50 28.5 +1 proteasome subunit
HIST2H4A 2.1 30 5.0 28 29 +1 histone cluster 2, H4a
CD147 1.8 68 9.5 6 37 +1 Tumor progression
MAPRE2 2.1 26 4.0 48 37 +1 Homology to APC
SGSH 2.1 24 3.6 58 41 +2 degradation of heparan sulfate
CCDC58 1.8 70 6.8 13 41.5 - coiled-coil domain containing 58
BLVRA 1.8 77 5.7 22 49.5 +1 biliverdin reductase A
NUCB2 1.9 56 4.1 43 49.5 +1 nucleobindin 2
EID1 3.4 6 3.0 94 50 +1 EP300 interacting inhibitor of differentiation
ASPSCR1 2.1 25 3.1 80 52.5 - alveolar soft part sarcoma
SGK 1.7 89 4.4 35 62 - serum/glucocorticoid regulated kinase
DBN1 2.3 19 2.9 106 62.5 - actin binding
Top 20 transcripts enriched by miR-US25-1 following RISC immunoprecipitation. Enrichment was determined by dividing total RNA levels by the levels of RNA detected
following IP. Fold enrichment represents enrichment of miR-US25-1 transcripts compared to negative control and is representative of 2 biological replicates. Superscript
numbers attached to gene names indicate miR-US25-1 target sites within these transcripts as follows;
1 = 7 to 8 base target within the 59UTR,
2 = target site without strict seed sequence complementarity within 59UTR,
3 = 7 base target within coding region (see Figure S1 for details).
doi:10.1371/journal.ppat.1000967.t001
Figure 3. Majority of miR-US25-1 target sites reside within
59UTRs. Pie chart shows the percentage of miR-US25-1 seed matches
within the 59UTR, ORF or 39UTR of top 50 enriched transcripts.
doi:10.1371/journal.ppat.1000967.g003
Table 2. Over representation of seed sequence target sites
within top 50 enriched transcripts.
Seed region Target 59 Match 59 P-value 39 Match 39 P-value
2–8 GAGCGGU 14 1.2e-14 1 0.36
1–7 AGCGGUU 10 5.5e-11 4 2.5e-3
1–8 GAGCGGUU 5 8.0e-7 1 0.091
2–8 G:U GGGCGGU 3 0.13 1 0.55
2–8 G:U GAGUGGU 1 0.37 3 0.51
2–8 G:U GGGUGGU 0 1.0 1 0.98
1–7 G:U GGCGGUU 0 1.0 0 1.0
1–7 G:U AGUGGUU 1 0.33 1 0.98
1–7 G:U GGUGGUU 1 0.44 0 1.0
Statistical overrepresentation of miR-US25-1 seed sequences in top 50 enriched
genes. Targets represent either nucleotides 1–7, 2–8 or 1–8 of miR-US25-1 seed
region. Also shown are the same targets allowing for potential G:U base pairing
(italicized).
doi:10.1371/journal.ppat.1000967.t002
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specific to the top target cyclin E2 and TRIM28. Although
TRIM28 was not in the top 20 targets shown in Table 2, it was the
top target following immunoprecipitation of tagged Ago2 from
cells transfected with the pSIREN construct (Table S1). As shown
in Figure 5a, cyclin E2 and TRIM28 were effectively enriched
from cells infected with HCMV compared to the uninfected
control cells. In addition, immunoprecipitation using a pre-bleed
control serum, which is not expected to pull down Ago2, did not
result in enrichment, indicating that the effect was specifically due
to association with RISC complexes.
To determine the specific effects of miR-US25-1 on the
expression of target proteins in the context of viral infection,
miR-US25-1 pre-miRNA coding region was deleted from the
virus. As shown in Figure 5b, successful disruption of miR-US25-1
expression was confirmed by RT-PCR analysis. Cells infected with
wild type HCMV express high levels of both miR-US25-1 and
miR-UL112-1, whereas miR-US25-1 levels were below back-
ground in cells infected with the knockout virus. miR-UL112-1
levels were equivalent to wild type levels indicating efficient
infection with the miR-US25-1 knockout virus. Low (MOI 0.5 –
Figure 5c) and high (MOI 10 – supplementary Figure S2c)
multiplicity growth curve analysis show the knockout virus was
able to replicate with wild type kinetics in human primary
fibroblast cells. The effects of virally expressed miR-US25-1 on
two top targets, cyclin E2 and TRIM28, were determined by
western blot analysis. As cyclin E protein levels are regulated
throughout the cell cycle, various serum conditions were used to
look at the effects of virus infection during normal cycling
populations, populations arrested by serum starvation and cells
induced from a resting state using replacement of serum. Western
blot analysis indicates that serum starvation effectively repressed
cyclin E2 expression as expected and serum rescue resulted in
resumption of cyclin E2 expression. Furthermore, as is the case
with cyclin E1, cyclin E2 levels were induced by HCMV infection
Figure 4. miR-US25-1 represses gene expression. (a) Schematic representation of miR-US25-1 target transcripts, cyclin E2 and (b) H3F3B. Red
boxes represent the open reading frames, green boxes the UTRs. The position of the target site within the 5UTR is indicated as well as the predicted
binding between miR-US25-1 and target sites. The seed region is highlighted in red. (c) 59UTR and promoter region of cyclin E2 (CCNE2) and H3F3B
were cloned upstream of a luciferase reporter construct. Cells were cotransfected with firefly luciferase (Fluc) constructs and either miR-US25-1
expression plasmid or a negative control plasmid. Following RISC-IP analysis, levels of luciferase transcript were analyzed by RT-PCR and enrichment
determined by comparing IP levels with total levels. Target sites were replaced with an EcoRI site to create deletion constructs. Bars represent the fold
increase in enrichment following miR-US25-1 expression compared to control. Transcript levels were normalized to GAPDH. (d) Luciferase constructs
described above were cotransfected with renillin luciferase plasmid and either miR-US25-1 expression plasmid (US25-1) or the control plasmid (NEG).
Luciferase activity was normalized to renillin levels then calculated as percentage of the negative control, which was set to 100%. Error bars indicate
s.d. from 3 independent experiments. Equivalent western blots for each transfection is shown below luciferase graph indicating Fluc protein levels.
doi:10.1371/journal.ppat.1000967.g004
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Figure 5. miR-US25-1 targets 59UTR’s in context of viral infection. (a) RISC-IP analysis was conducted on uninfected human primary fibroblast
cells or cells infected with HCMV using a direct Ago2 antibody. Results show levels of enrichment of cyclin E2 or TRIM28 transcript from infected cells
compared to uninfected cells. RISC-IP was also conducted using pre-bleed antibody derived from rabbits before antigen inoculation. (b) miR-US25-1
was deleted from HCMV. Levels of miR-US25-1 and miR-UL112-1 were determined by RT-PCR analysis following infection of human primary fibroblast
cells with either wild type HCMV or the knock out virus. RNA from uninfected cells is used as a negative control. (c) Viral growth of miR-US25-1 knock
out virus was compared to wild type HCMV following low (MOI of 0.5) or high (MOI of 10) multiplicity infection of human primary fibroblast cells. Cells
plus supernatant were collected at indicated times and assayed on primary human fibroblast cells by limiting dilution (d) Levels of cyclin E2 and
TRIM28 protein were determined following high multiplicity infection (MOI of 10) of human primary fibroblast cells with either wild type virus or miR-
US25-1 knock out virus. Cells were either grown in normal serum conditions, serum starved conditions or serum starved cells with serum replaced
10 hours prior to harvest. Cells were harvested 72 hours post infection. Relative densities of bands normalized to GAPDH are shown below each lane.
Total RNA was also isolated and transcript levels for cyclin E2 (e) and TRIM28 (f) determined by RT-PCR. Transcript copy number was normalized to
GAPDH levels.
doi:10.1371/journal.ppat.1000967.g005
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in all serum conditions. Figure 5d also shows a clear increase in
expression of cyclin E2, and to a lesser extent TRIM28, in cells
infected with the miR-US25-1 knock-out virus compared to wild
type infected cells, demonstrating that miR-US25-1 reduces the
expression of these target genes. Time course experiments show
that expression of cyclin E2 was equivalent between wild type and
KO virus infection 24 hours post infection, and regulation by
miR-US25-1 does not occur until approximately 48 hours post
infection (supplementary Figure S2d). This concurs with previous
studies showing levels of miR-US25-1 increase during the
progression of the viral infection and suggests that miR-US25-1
levels at 24 hours post infection are not high enough to produce
measurable effects on cyclin E2 protein levels [7]. A slight increase
(approximately 1.5 fold) was observed in RNA levels of cyclin E2
and TRIM28, consistent with previous reports that miRNA
targeting can cause moderate decreases in transcript levels
(Figure 5e and f). Following serum rescue, levels of cyclin E2
RNA increase in mock infected cells. The fact that cyclin E2
protein levels do not show a similar increase at this time likely
reflects the delay between transcriptional activation and protein
translation.
Discussion
These observations provide the first comprehensive identifica-
tion of multiple cellular targets of a viral miRNA using RISC-IP
analysis. Strikingly, the study demonstrates that miR-US25-1
mediates inhibition of gene expression through the novel
mechanism of targeting 59UTR sequences. Furthermore, we
demonstrate that miR-US25-1 targets multiple cellular genes
related to cell cycle control. To our knowledge this is the first
example of a viral miRNA targeting 59UTRs and is the first
demonstration of an endogenous miRNA repressing protein
expression through targeting sequences within the 59UTR.
These results are in contrast to previous studies demonstrating
miRNA targeting of 59UTRs. Targeting of cellular 59UTRs by
miR-10a moderately increased gene expression while targeting of
the HCV genome by miR-122 was shown to be required for viral
replication [20,21]. Clearly, targeting of 59UTRs by miRNAs can
mediate distinct positive or negative regulatory effects depending
on the context. It will be interesting to determine how miRNAs
mediate distinct regulatory effects and whether inhibition of
protein expression through miRNA targeting of 59UTRs is more
common than previously thought, or whether this mechanism is
specific to miR-US25-1 or viral miRNAs.
The functions of a number of cellular genes identified in this
study have important implications for the biology of HCMV and
viruses in general. Infection with HCMV has long been known to
manipulate the cell cycle by altering the expression of cyclin
dependent kinases (CDKs) and their associated cyclin subunits
[27]. Cyclin E proteins are expressed early in G1 phase where they
bind to and activate CDK2, resulting in progression into S phase.
Previous studies have demonstrated that HCMV induces resting
G0 cells to enter the cell cycle whereupon the virus blocks further
progression at the G1/S boundary [34]. By blocking the cell cycle
at the G1/S phase the virus creates a cellular environment
conducive for DNA replication. HCMV induced expression of
cyclin E1 is thought to play an important role in driving cells into
the G1/S phase [35].
Here, we show the virus also induces expression of cyclin E2
early in infection, then moderates cyclin E2 protein levels through
targeting by miR-US25-1. miR-US25-1 may therefore function as
a rheostat regulator, modulating expression of cyclin E2 to
generate the correct balance in protein induction. This may
contribute to the viruses ability to block cell cycle progression at
the G1/S phase, or to protect the infected cell against toxicity.
Over-expression of cyclin E has been linked to sensitivity to
apoptosis and unchecked induction of cyclin E2 may be
detrimental to the virus [36,37].
Alternatively, miR-US25-1 function may be unrelated to cell
cycle control. Recent studies have suggested that herpesvirus
miRNAs may be important during persistent or latent infection
[9,11–13]. HCMV is thought to reside within haematopoietic stem
cell populations that give rise to latently infected monocyte and
macrophage cells [38,39]. By targeting genes involved in cell cycle
progression and differentiation, the virus could manipulate the
production of cells generated by latently infected progenitors to
favor certain cell types such as monocytes and macrophages.
Although deletion of US25-1 did not result in a phenotypic effect
on the replication following infection of primary human fibroblast
cells, regulation of the target genes identified may be important in
other cell types, such as endothelial cells or macrophage cells, or
during the latent or persistent phase of the virus life cycle.
Finally, the study of viral miRNAs may provide a powerful
method for identifying novel cellular regulatory and antiviral
pathways. This study suggests that viral miRNAs, like cellular
miRNAs, may function through targeting multiple genes within
related pathways. Many of target genes identified in this study are
functionally related and contain the same 59UTR sequence motif.
It is likely that miR-US25-1 has evolved to target this 59UTR
motif, thereby subverting the regulatory pathway for the benefit of
the virus. Investigation of viral miRNAs may therefore lead to
discovery of additional novel cellular pathways.
Materials and Methods
RISC-IP analysis
RISC-IP analysis was carried as out previously described
[22,23]. In brief HEK293 cells stably transfected with c-myc
tagged Ago2 were transfected with the pSIREN expression
plasmid or a synthetic biotinylated siRNA using Fugene (Roche)
or RNAimax (Invitrogen) according to manufacturers specifica-
tions. Three days post infection cells were lysed, samples taken for
total RNA levels and miRNP complexes immunoprecipitated
using anti-c-myc antibody beads (Sigma) or streptavidin beads.
RNA was isolated using Trizol and analyzed for quality using an
Agilent Bioanalyzer and transcript levels determined on the
Illumina HumanRef-8 platform. Microarray data was analyzed
using Gene sifter software. Enrichment of specific transcripts,
through association with miRNP complexes was determined by
dividing the immunoprecipitated levels of transcripts by the total
levels, thereby taking into consideration any direct effects of miR-
US25-1 on transcript levels. This approach initially identifies any
transcript associated with any miRNP complex. To specifically
identify those transcripts targeted by miR-US25-1, the enrichment
profile was compared to cells transfected with a negative control
vector, resulting in exclusion of transcripts enriched through
association with cellular miRNAs. Transcripts were then ranked
according to the level of enrichment with the highest enriched
transcripts considered potential targets of miR-US25-1. For
example, in cells transfected with the negative control plasmid,
cyclin E2 levels were 1958 in the total sample and 2219 in the IP
sample, giving an enrichment value of 1.1. In cells transfected with
miR-US25-1 expression plasmid, cyclin E2 levels were 2718 in the
total sample compared to 16744 in the IP sample, giving an
enrichment value of 6.1. By dividing the enrichment value from
cells transfected with US25-1 compared to the control cells (6.1/
1.1) the overall enrichment ratio is calculated as 5.4.
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Argonaute specific antibody was generated by immunization of
rabbits with a peptide corresponding to the N terminal region of
Argonaute 2 (5-MYSGAGPALAPPAPPPPIQGYAFKPPPRPD39).
For virus infections, primary human fibroblast cells (Clontech) were
infected at highmultiplicity (MOI of 10) with the laboratory lab strain
AD169. RISC-IP analysis was conducted as above, except antibody
to endogenous Ago2 was used to immunoprecipitated miRNP
complexes and transcript levels determined using direct RT-PCR
primer probe sets (ABI) for CCNE2, TRIM28, and GAPDH.
Sequence analysis
Transcript sequences were down loaded from NCBI using RefSeq
ID’s. Transcript data sets were searched for seed sequence matches
using a Java based script program. Statistical overrepresentation of
seed matches within the top 50 transcripts from Table S3 was
determined by Fisher exact test. Predicted binding between miR-
US25-1 and target sites within the 10most highly enriched transcripts
were determined using the online RNA folding algorithm, mfold
(http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1.cgi).
Luciferase assay
59UTRs and approximately 500 bases upstream sequence of
target genes were PCR amplified from human fibroblast DNA and
cloned upstream of the pGL4 luc2 (Promega) firefly luciferase
construct. 59UTR luciferase constructs were cotransfected with a
renillin control construct and miRNA mimics using Lipofectamine
2000 (Invitrogen) into HEK293 cells according to manufacturers
instructions. Cells were harvested 18 hours post transfection and
luciferase levels measured using Promega’s dual reporter kit.
Protein levels were determined using an anti-firefly luciferase
antibody (Sigma).
Western blot analysis
Human primary fibroblast cells were grown in either 10%
serum or 0.01% serum for 18 hours before infection at high
multiplicity (MOI of 10) with either wild type AD169 or miR-
US25-1 knock out virus. Serum rescued cells were recovered with
10% serum 48 hours post infection. Seventy-two hours post
infection, cells were harvested using RIPA buffer and total protein
levels determined by BCA analysis. Thirty micrograms total
protein was loaded and proteins detected using primary antibodies
to cyclin E2 (Abcam), TRIM28 (Cellsignal), and GAPDH (Abcam)
and secondary HRP-conjugated antibodies (Jackson labs) with
ECL reagent (GE bioscience).
miRNA expression cassettes
The predicted pre-miRNA region of miR-US25-1 plus
approximately 100 additional bases were PCR amplified (primers
shown in supplementary Table S4) and cloned into the pSIREN
expression plasmid (Clontech). pSIREN NEG was supplied by
Clontech. Synthetic miRNA mimics were purchased from
Dharmacon.
miR-US25-1 KO virus
miR-US25-1 pre-miRNA coding region was deleted from
AD169 BAC clone using BAC technology as previously described
[40]. Briefly a PCR amplified cassette containing FRT flanked
Kanamycin was recombined into AD169 BAC genome replacing
the miR-US25-1 coding region using primers listed in Table S4.
The Kanamycin cassette was then removed by recombining the
FRT sites through inducible FLIP recombinase. The resulting
BAC was isolated and electroporated into human primary
fibroblast cells to produce infectious virus.
RT-PCR analysis
Total RNA was harvested using Trizol and concentrations
determined on a nano-drop spectrophotometer. 100 ng of total
RNA was then reverse transcribed using either random hexemers
or specific RT primers for miRNA RT-PCR. Specific primer
probe sets were then used for real time amplification using
TAQMAN probes. All primers and probes shown in Table S4.
Gene specific primer probe sets were from ABI.
Supporting Information
Figure S1 Predicted miR-US25-1 target sites in enriched
transcripts. Schematic representation of enriched transcripts showing
position and predicted base pairing of miR-US25-1 to binding sites.
ORFs are shown in red with UTRs shown in green. Seed regions are
highlighted in red. miRNA binding was predicted using mfold.
Found at: doi:10.1371/journal.ppat.1000967.s001 (1.33 MB EPS)
Figure S2 (a) To confirm the effectiveness of the generated
antibody, HEK293 cells were transiently transfected with Ago1, 2
or 3 expression plasmids, or mock transfected (M), and protein
extracts analyzed by western blot analysis. The generated
antibody reacted strongly with endogenous and transiently
expressed Ago2, but not with Ago1 or 3. (b) The Ago2 antibody
efficiently immunoprecipitates Ago2. 293 HEK cells stably
expressing myc-tagged Ago2 were labeled with S35 methionine
and immunoprecipitated with either 5, 10 or 15 ul of Ago2
antibody or 10 ul c-myc antibody (10 ul Ago2 antibody for
denatured sample). Both denatured (D - lane 2) and non-
denatured (N - lanes 3, 4 and 5) samples were Immunoprecip-
itated then separated on a 10% SDS gel and exposed to film
overnight. Bands corresponding to Ago2 were detected with both
Ago2 antibody and the c-myc antibody. No bands were detected
using pre-bleed serum (Pre-bleed). (c) AD169 US25-1 KO virus
grows with the same kinetics as wild type in primary human
fibroblast cells infected at a multiplicity of 10 pfu per cell. (d)
Levels of cyclin E2 were determined by western blot analysis 24,
48 and 72 hours following infection of primary human fibroblast
cells with either wild type or US25-1 KO virus. Deletion of
US25-1 resulted in higher levels of cyclin E2 only after 48 hours
infection. GAPDH is shown as a loading control.
Found at: doi:10.1371/journal.ppat.1000967.s002 (3.00 MB EPS)
Table S1 Full data set for RISC-IP analysis of miR-US25-1 pull
downs using myc-Ago2 approach. Signal levels for total RNA and
IP RNA levels are shown for biological replicates A and B. IP/
Total ratios were generated for NEG and miR-US25-1 transfected
cells and enrichment determined by dividing miR-US25-1 ratio by
NEG ratio. Enrichment from the biological replicates were
averaged and genes sorted based on this value.
Found at: doi:10.1371/journal.ppat.1000967.s003 (5.70 MB ZIP)
Table S2 Full data set for RISC-IP analysis of miR-US25-1 pull
downs using biotin approach. Data analyzed as for Table S1.
Found at: doi:10.1371/journal.ppat.1000967.s004 (5.51 MB ZIP)
Table S3 Data sets were combined by determining the average
rank from Tables S1 and S2 based on average enrichment.
Number and type of target within the 59UTR is also shown for
each gene. Transcripts containing miR-US25-1 target sites in top
50 are highlighted in yellow.
Found at: doi:10.1371/journal.ppat.1000967.s005 (2.53 MB ZIP)
Table S4 List of primers and probes used for cloning and RT-
PCR analysis.
Found at: doi:10.1371/journal.ppat.1000967.s006 (0.05 MB
DOC)
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